Aprea Therapeutics
Earnings Surprise
Analysts estimated APRE earnings of $-0.40 per share this quarter (Q4). APRE's actual earnings were $-0.32 per share.
APRE EPS surprise of 19.56%Analysts estimated APRE earnings of $-0.35 per share this quarter (Q3). APRE's actual earnings were $-0.47 per share.
APRE EPS surprise of -36.11%Analysts estimated APRE earnings of $-0.76 per share this quarter (Q2). APRE's actual earnings were $-0.53 per share.
APRE EPS surprise of 30.25%Analysts estimated APRE earnings of $-0.70 per share this quarter (Q4). APRE's actual earnings were $-0.49 per share.
APRE EPS surprise of 30.04%Analysts estimated APRE earnings of $-0.76 per share this quarter (Q3). APRE's actual earnings were $-0.64 per share.
APRE EPS surprise of 15.78%Analysts estimated APRE earnings of $-0.65 per share this quarter (Q2). APRE's actual earnings were $-0.58 per share.
APRE EPS surprise of 10.45%Analysts estimated APRE earnings of $-0.79 per share this quarter (Q1). APRE's actual earnings were $-0.67 per share.
APRE EPS surprise of 15.40%Analysts estimated APRE earnings of $-0.79 per share this quarter (Q4). APRE's actual earnings were $-0.92 per share.
APRE EPS surprise of 16.63%Analysts estimated APRE earnings of $-1.19 per share this quarter (Q3). APRE's actual earnings were $-0.86 per share.
APRE EPS surprise of -27.54%